×
About 22,108 results

ALLMedicine™ Hypoglycemia Center

Research & Reviews  10,573 results

PERFORMANCE OF AN AUTOMATED INSULIN DELIVERY (AID) SYSTEM: RESULTS OF EARLY PHASE FEASI...
https://doi.org/10.1089/dia.2020.0318
Diabetes Technology & Therapeutics; Christiansen M, Bartee A et. al.

Sep 17th, 2020 - Automated insulin delivery (AID) systems have demonstrated improvements in time-in-range (TIR, blood glucose 70-180 mg/dL) without increasing hypoglycemia. Testing a closed loop system in an inpatient environment with supervised challenges allows ...

Relationship of glycemic derangement using continuous glucose monitoring system with sl...
https://doi.org/10.1002/dmrr.3407
Diabetes/metabolism Research and Reviews; Salah NY, Abido AY et. al.

Sep 16th, 2020 - Glycemic derangement has been linked to sleep disruption. However, the impact of glycemic derangement on sleep pattern among children with type 1 diabetes (C-T1D) remains unraveled. To assess the effect of nocturnal hyperglycemia and clinically si...

Provider Response to Critical Action Values for Hypoglycemia in the Ambulatory Setting:...
https://doi.org/10.1007/s11606-020-06225-y
Journal of General Internal Medicine; Ashok A, Abusamaan MS et. al.

Sep 16th, 2020 - The blood glucose level triggering a critical action value (CAV) for hypoglycemia is not standardized, and associated outcomes are unknown. To evaluate the clinical consequences of, and provider responses to, CAVs for hypoglycemia. Retrospective c...

Management of type 2 diabetes for prevention of cardiovascular disease. An expert opini...
https://doi.org/10.1016/j.numecd.2020.07.012
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Napoli R, Formoso G et. al.

Sep 15th, 2020 - Type 2 diabetes mellitus is characterized by an increased risk of developing long-term cardiovascular complications. Several underlying mechanisms have been proposed for the diabetes-related increase in cardiovascular risk, i.e. chronic hyperglyce...

Dissimilar regulation of glucose and lipid metabolism by leptin in two strains of gibel...
https://doi.org/10.1017/S0007114520003608
The British Journal of Nutrition; Wu L, Li H et. al.

Sep 14th, 2020 - Previous nutritional studies have shown that insulin regulation is different between DT and A strains of gibel carp. As leptin plays a pivotal role in the effects of insulin, we hypothesized that leptin regulation of glucose and lipid metabolism w...

see more →

Guidelines  49 results

Guideline No. 393-Diabetes in Pregnancy.
https://doi.org/10.1016/j.jogc.2019.03.008
Journal of ObstEtrics and Gynaecology Canada : JOGC = Journal D'obstEtrique Et Gynecologie Du Canada : JOGC; Berger H, Gagnon R et. al.

Dec 1st, 2019 - This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy. The outcomes evaluated were short and long-term maternal outcomes including pre-eclampsia, Caesarean section, future diabetes and ot...

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
https://www.nejm.org/doi/full/10.1056/NEJMoa1911303
The New England Journal of Medicine; McMurray,J.,et al

Sep 18th, 2019 - BACKGROUND In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the eff...

Xeris Pharmaceuticals Receives U.S. Fda Approval For Gvoke™ (Glucagon), The First Ready-to-use Stable Liquid Glucagon For Severe Hypoglycemia
https://xerispharma.gcs-web.com/news-releases/news-release-details/xeris-pharmaceuticals-receives-us-fda-approval-gvoketm-glucagon

Sep 9th, 2019 - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received reg...

BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA
https://investor.lilly.com/news-releases/news-release-details/baqsimitm-glucagon-nasal-powder-3-mg-first-and-only-nasally

Jul 23rd, 2019 - The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and above, Eli Lilly and Company (NYSE: LLY) announced today. BAQSIMI i...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

see more →

Drugs  89 results see all →

Clinicaltrials.gov  10,793 results

PERFORMANCE OF AN AUTOMATED INSULIN DELIVERY (AID) SYSTEM: RESULTS OF EARLY PHASE FEASI...
https://doi.org/10.1089/dia.2020.0318
Diabetes Technology & Therapeutics; Christiansen M, Bartee A et. al.

Sep 17th, 2020 - Automated insulin delivery (AID) systems have demonstrated improvements in time-in-range (TIR, blood glucose 70-180 mg/dL) without increasing hypoglycemia. Testing a closed loop system in an inpatient environment with supervised challenges allows ...

Relationship of glycemic derangement using continuous glucose monitoring system with sl...
https://doi.org/10.1002/dmrr.3407
Diabetes/metabolism Research and Reviews; Salah NY, Abido AY et. al.

Sep 16th, 2020 - Glycemic derangement has been linked to sleep disruption. However, the impact of glycemic derangement on sleep pattern among children with type 1 diabetes (C-T1D) remains unraveled. To assess the effect of nocturnal hyperglycemia and clinically si...

Provider Response to Critical Action Values for Hypoglycemia in the Ambulatory Setting:...
https://doi.org/10.1007/s11606-020-06225-y
Journal of General Internal Medicine; Ashok A, Abusamaan MS et. al.

Sep 16th, 2020 - The blood glucose level triggering a critical action value (CAV) for hypoglycemia is not standardized, and associated outcomes are unknown. To evaluate the clinical consequences of, and provider responses to, CAVs for hypoglycemia. Retrospective c...

Management of type 2 diabetes for prevention of cardiovascular disease. An expert opini...
https://doi.org/10.1016/j.numecd.2020.07.012
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Napoli R, Formoso G et. al.

Sep 15th, 2020 - Type 2 diabetes mellitus is characterized by an increased risk of developing long-term cardiovascular complications. Several underlying mechanisms have been proposed for the diabetes-related increase in cardiovascular risk, i.e. chronic hyperglyce...

Dissimilar regulation of glucose and lipid metabolism by leptin in two strains of gibel...
https://doi.org/10.1017/S0007114520003608
The British Journal of Nutrition; Wu L, Li H et. al.

Sep 14th, 2020 - Previous nutritional studies have shown that insulin regulation is different between DT and A strains of gibel carp. As leptin plays a pivotal role in the effects of insulin, we hypothesized that leptin regulation of glucose and lipid metabolism w...

see more →

News  555 results

Smoking, hypoglycemia, kidney function tied to vision loss in type 2 diabetes
https://www.mdedge.com/familymedicine/article/219004/diabetes/smoking-hypoglycemia-kidney-function-tied-vision-loss-type-2?channel=255
MDedge Endocrinology; Steve Cimino

Mar 13th, 2020 - Several risk factors, including smoking, a previous severe hypoglycemic event, and poorly functioning kidneys, can lead to vision loss in patients with type 2 diabetes, according to new findings published in the Journal of Diabetes and its Complic.

NPH insulin: It remains a good option
https://www.mdedge.com/clinicianreviews/article/218305/diabetes/nph-insulin-it-remains-good-option/page/0/1?channel=205

Mar 3rd, 2020 - Per 1000 person-years, there was no significant difference in hypoglycemia-related ED visits or hospital admissions between the analog and NPH groups (11. 9 events vs 8.

Less gestational weight gain seen with metformin
https://www.mdedge.com/clinicianreviews/article/216914/obstetrics/less-gestational-weight-gain-seen-metformin?channel=53
Kari Oakes

Feb 7th, 2020 - GRAPEVINE, TEX. * – Pregnant women with type 2 diabetes or prediabetes had significantly less gestational weight gain if they had metformin exposure at any point in their pregnancies, with no differences in infant birth weight or postnatal infant h.

Can insulin plus metformin improve pregnancy outcomes in women with type 2 diabetes?
https://www.mdedge.com/fedprac/article/214703/obstetrics/can-insulin-plus-metformin-improve-pregnancy-outcomes-women-type-2/page/0/1?channel=53

Dec 23rd, 2019 - Currently, the multisite MOMPOD trial (Medical Optimization of Management of T2DM Complicating Pregnancy) is randomizing 950 women to insulin plus 1,000 mg metformin twice daily or insulin plus placebo. The primary outcome of the trial is a compos.

Is strict glycemic control meaningless for older adults?
https://www.mdedge.com/clinicianreviews/article/213780/diabetes/strict-glycemic-control-meaningless-older-adults/page/0/3?channel=205

Dec 7th, 2019 - Similarly, in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS), the DPP-4 inhibitor did not increase severe hypoglycemia in the subgroup of participants aged 75 years and older. And in several of the recent cardiovascular outc.

see more →

Patient Education  49 results see all →